MercadoLibre’s MELI valuation may be a concern for some investors. The stock is trading at a premium compared to the broader Zacks Internet – Commerce industry. As of the latest data, MELI’s forward ...

On FOLD's first-quarter 2025 earnings call, investors are likely to focus on the sales of lead drug Galafold and the combo drug, Pombiliti + Opfolda.